CSIMarket
 


Cytomx Therapeutics Inc   (CTMX)
Other Ticker:  
 
 

CTMX's EPS from Cont. Operations Growth by Quarter and Year

Cytomx Therapeutics Inc 's EPS from Cont. Operations results by quarter and year




CTMX EPS from Cont. Operations (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -0.42 -1.55 -0.32
III Quarter September 0.04 -0.35 -0.35 -0.32
II Quarter June -0.02 -0.37 -0.30 -0.34
I Quarter March -0.05 -0.37 -0.26 0.27
FY   -0.03 -1.51 -2.46 -0.71



CTMX EPS from Cont. Operations third quarter 2023 Y/Y Growth Comment
Cytomx Therapeutics Inc in the third quarter 2023 achieved EPS from Cont. Operations of $ 0.04 compare to EPS loss from Cont. Operations recorded in same quarter a year ago.

According to the results reported in the third quarter 2023, Cytomx Therapeutics Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Cytomx Therapeutics Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2023.




CTMX EPS from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cytomx Therapeutics Inc 's third quarter 2023 EPS from Cont. Operations $ 0.04 CTMX's Income Statement
Cytomx Therapeutics Inc 's third quarter 2022 EPS from Cont. Operations $ -0.35 Quarterly CTMX's Income Statement
New: More CTMX's historic EPS from Cont. Operations Growth >>


CTMX EPS from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Cytomx Therapeutics Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CTMX's III. Quarter Q/Q EPS from Cont. Operations Comment
This reversal of fortune III. Quarter 2023where Cytomx Therapeutics Inc published EPS from Cont. Operations of $ 0.04 should is inception of improved results.Cytomx Therapeutics Inc announced in the III. Quarter 2023 EPS from Cont. Operations of $ 0.04 compare to EPS loss from Cont. Operations recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Cytomx Therapeutics Inc achieved highest sequential EPS from Cont. Operations growth. While Cytomx Therapeutics Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CTMX's III. Quarter Q/Q EPS from Cont. Operations Comment
This reversal of fortune III. Quarter 2023where Cytomx Therapeutics Inc delivered EPS from Cont. Operations of $ 0.04 could be inception of better results.Cytomx Therapeutics Inc announced in the III. Quarter 2023 EPS from Cont. Operations of $ 0.04 compare to EPS loss from Cont. Operations recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Cytomx Therapeutics Inc achieved highest sequential EPS from Cont. Operations growth. While Cytomx Therapeutics Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Cytomx Therapeutics Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ -0.45 $ -0.84 $ -1.19 $ -1.51 $ -2.64
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment


Cytomx Therapeutics Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment


Cytomx Therapeutics Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
CTMX's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for CTMX's Competitors
EPS from Cont. Operations Growth for Cytomx Therapeutics Inc 's Suppliers
EPS from Cont. Operations Growth for CTMX's Customers

You may also want to know
CTMX's Annual Growth Rates CTMX's Profitability Ratios CTMX's Asset Turnover Ratio CTMX's Dividend Growth
CTMX's Roe CTMX's Valuation Ratios CTMX's Financial Strength Ratios CTMX's Dividend Payout Ratio
CTMX's Roa CTMX's Inventory Turnover Ratio CTMX's Growth Rates CTMX's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2023
Shockwave Medical Inc -2.06%$ -2.062 
Corcept Therapeutics Inc-3.13%$ -3.125 
Viatris Inc -3.45%$ -3.448 
Henry Schein Inc-3.64%$ -3.636 
Universal Health Services Inc -3.97%$ -3.968 
National Research Corporation-5.88%$ -5.882 
Mettler toledo International Inc -5.99%$ -5.990 
The Pennant Group Inc -6.25%$ -6.250 
Quest Diagnostics Inc-9.55%$ -9.545 
Charles River Laboratories International inc -10.53%$ -10.526 
Carlisle Companies Incorporated-11.00%$ -10.998 
Zimmer Biomet Holdings Inc -15.22%$ -15.217 
Stryker Corp-15.74%$ -15.741 
Tenet Healthcare Corp-18.18%$ -18.182 
Amgen Inc -19.45%$ -19.451 
Hologic Inc-22.07%$ -22.070 
Regeneron Pharmaceuticals Inc -22.99%$ -22.989 
Zynex inc -23.08%$ -23.077 
Dariohealth Corp -23.44%$ -23.438 
Pediatrix Medical Group Inc -25.71%$ -25.714 
Entera Bio Ltd -27.27%$ -27.273 
U S Physical Therapy Inc-29.17%$ -29.167 
Avantor Inc -36.00%$ -36.000 
Ufp Technologies Inc -40.70%$ -40.698 
Biomx Inc -43.48%$ -43.478 
Laboratory Corporation Of America Holdings-45.78%$ -45.780 
Pacific Health Care Organization Inc -50.00%$ -50.000 
Royalty Pharma Plc-50.00%$ -50.000 
Staar Surgical Company-52.38%$ -52.381 
Repligen Corp-54.79%$ -54.795 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com